000 01464 a2200325 4500
005 20250517232253.0
264 0 _c20191119
008 201911s 0 0 eng d
022 _a1477-092X
024 7 _a10.1177/1078155218791309
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClover, Todd
245 0 0 _aTransformation of a non-secretory neuroendocrine tumor to insulinoma after treatment with Sunitinib: A case report and review of the literature.
_h[electronic resource]
260 _bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_cSep 2019
300 _a1516-1519 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aCell Transformation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInsulinoma
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuroendocrine Tumors
_xdiagnosis
650 0 4 _aPancreatic Neoplasms
_xdiagnosis
650 0 4 _aSunitinib
_xadverse effects
700 1 _aAbdelkader, Amrou
700 1 _aGuru Murthy, Guru Subramanian
773 0 _tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_gvol. 25
_gno. 6
_gp. 1516-1519
856 4 0 _uhttps://doi.org/10.1177/1078155218791309
_zAvailable from publisher's website
999 _c28711930
_d28711930